Abstract:Introduction: The microphthalmia transcription factor Mitf has been shown to regulate B cell activation and tolerance. However, the underlying B cell-specific mechanisms responsible, and those that distinguish Mitf from closely related Mitf/TFE (MiT) transcription factors Tfe3, Tfeb, and Tfec, remain obscure. Methods: Two complementary mouse models of Mitf and MiT deficiency were used: the Mitf mi-vga9/mi-vga9 systemic loss-of-function mutation, and B-cell specific MiT family inactivation via transgenic expression of a trans-dominant negative (TDN) protein (TDN-B). These models were employed to identify MiT family candidate target genes and pathways. Results: Both models displayed spontaneous splenomegaly coincident with elevated plasma cell numbers, autoantibody titers, and proteinuria. These abnormalities appeared dependent on T helper cells, but independent of other non-B cell intrinsic effects of systemic Mitf inactivation. MiT inactivation in B cells augmented aspects of lupus-like autoimmune disease on the C57BL/6-Fas lpr/lpr background. In both models, RNAseq of ex vivo resting B cells showed transcriptional upregulation of genes that control cell cycle, germinal center responses, and plasma cell differentiation. Among the genes strongly upregulated in both models were Socs6, Isp53 (Baiap1), S1pR2, and IgG2b/c. Mitf null B cells, but not TDN-B cells, showed evidence of type I interferon dysregulation. Discussion: These studies clarify Mitf's role as 1) a key regulator of a B cell intrinsic germinal center program that influences self-tolerance through novel target genes, and 2) a regulator of systemic inflammatory processes that can impact the B cell microenvironment. This distinction of Mitf's function from that of related MiT transcription factors advances our understanding of B cell regulation and autoimmunity.

MiR-17~92 family microRNAs are critical regulators of T follicular helper cell differentiation (P1133)

MicroRNAs of the Mir-17∼92 Family Are Critical Regulators of TFH Differentiation

The Mir-17∼92 Mirnas Promote Plasma Cell Differentiation by Suppressing SOCS3-mediated NIK Degradation.

The miR-1792 miRNAs promote plasma cell differentiation by suppressing SOCS3-mediated NIK degradation

MicroRNA-17-92 is Required for T-cell and B-cell Pathogenicity in Chronic Graft-Versus-host Disease in Mice.

MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice

miR-15/16 Restrain Memory T Cell Differentiation, Cell Cycle, and Survival

MiR-17-92 is Required for the Pathogenicity of T and B Cells in Chronic Gvhd

The B Cell Activation-Induced miR-183 Cluster Plays a Minimal Role in Canonical Primary Humoral Responses

miR-146a −/− deficiency in the DC compartment results in increased effector phenotype CD4+ and CD8+ T cells in response to LCMV infection

Molecular Control of Follicular Helper T cell Development and Differentiation

The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]

Critical roles of the miR-17∼92 family in thymocyte development, leukemogenesis, and autoimmunity

MicroRNA-155 Is Essential for the T Cell-Mediated Control of Helicobacter pylori Infection and for the Induction of Chronic Gastritis and Colitis

MicroRNA-155 Regulates MAIT1 and MAIT17 Cell Differentiation

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets

Foxo3 Promotes the Differentiation and Function of Follicular Helper T Cells.

TGF-β specifies T FH versus T H 17 cell fates in murine CD4 + T cells through c-Maf

Three Paralogous Clusters of the Mir-17~92 Family of Micrornas Restrain IL-12-mediated Immune Defense.

Expression of Foxp3 by T follicular helper cells in end-stage germinal centers

Mitf regulates gene expression networks implicated in B cell homeostasis, germinal center responses, and tolerance